GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (FRA:7XP) » Definitions » Issuance of Debt

Organon (FRA:7XP) Issuance of Debt : €962 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Organon Issuance of Debt?

Organon's Issuance of Debt for the three months ended in Sep. 2024 was €0 Mil.

Organon's Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 was €962 Mil.


Organon Issuance of Debt Historical Data

The historical data trend for Organon's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Issuance of Debt Chart

Organon Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Issuance of Debt
Get a 7-Day Free Trial - 1,242.86 8,380.95 - 73.36

Organon Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 962.44 -

Organon Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €962 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Organon Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Organon's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Organon Business Description

Traded in Other Exchanges
Address
30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Organon Headlines

No Headlines